BIWEEKLY DOCETAXEL-CISPLATIN IN CHEMO-NAIVE PATIENTS WITH ADVANCED SQUAMOUS CARCINOMA OF THE LUNG: A GALICIAN LUNG CANCER GROUP PHASE II STUDY

被引：0
|
作者：
Lazaro, Martin [1 ]
Vazquez, S. [2 ]
Jose Villanueva, Maria [3 ]
Firvida, J. L.
Amenedo, Margarita [4 ]
Afonso, Javier
Senin, Clara [3 ]
Campos, Begona
Huidobro, Gerardo [3 ]
Areses, Carmen [5 ]
机构：
[1] Complexo Hosp Univ, La Coruna, Spain
[2] Hosp Univ Lucus Augusti, Lugo, Spain
[3] Complexo Hosp Univ Vigo, Vigo, Spain
[4] Ctr Oncol Galicia, Galicia, Spain
[5] Complexo Hosp Univ Santiago De Compostela, Santiago De Compostela, Spain
来源：
JOURNAL OF THORACIC ONCOLOGY | 2011年 / 6卷 / 06期
关键词：
non-squamous; cisplatin; docetaxel;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S1278 / S1279
页数：2
相关论文
共 50 条
  • [31] Phase I/II trial of bexarotene (Targretin®) with chemotherapy for chemo-naive patients with advanced non-small cell lung cancer.
    Khuri, FR
    Rigas, JR
    Figlin, RA
    Gralla, RJ
    Reich, SD
    Hong, WK
    CLINICAL CANCER RESEARCH, 2000, 6 : 4487S - 4488S
  • [32] Biweekly docetaxel and vinorelbine as second-line treatment in advanced (stage IIIB plus IV) non-small-cell lung cancer (NSCLC).: A phase II study of the galician lung cancer group.
    Vázquez, S
    Huidobro, G
    Amenedo, M
    Firvida, JL
    Lázaro, M
    Del Río, L
    Villanueva, MJ
    Alvarez, E
    Ramos, M
    Casal, J
    Xeral, H
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 703S - 703S
  • [33] A phase II study of weekly irinotecan and capecitabine for chemo-naive patients with advanced NSCLC.
    Lee, JJ
    Han, JY
    Lee, DH
    Kim, HY
    Lee, HG
    Lee, SY
    Shin, EH
    Lee, JS
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 681S - 681S
  • [34] A phase I trial of afatinib and bevacizumab in chemo-naive patients with advanced non-small-cell lung cancer harboring EGFR mutations: Okayama Lung Cancer Study Group Trial 1404
    Ninomiya, Takashi
    Nogami, Naoyuki
    Kozuki, Toshiyuki
    Harada, Daijiro
    Kubo, Toshio
    Ohashi, Kadoaki
    Kuyama, Shoichi
    Kudo, Kenichiro
    Bessho, Akihiro
    Fukamatsu, Nobuaki
    Fujimoto, Nobukazu
    Aoe, Keisuke
    Shibayama, Takuo
    Sugimoto, Keisuke
    Takigawa, Nagio
    Hotta, Katsuyuki
    Kiura, Katsuyuki
    LUNG CANCER, 2018, 115 : 103 - 108
  • [35] Biweekly paclitaxel as second-line treatment in advanced non-small cell lung-cancer (NSCLC). A phase II study of the Lung Cancer Galician Group
    Vazquez-Estevez, S.
    Firvida, J.
    Huidobro, G.
    Leon, L.
    Lazaro, M.
    Salgado, M.
    Mel, J.
    Grande, C.
    Perez, E.
    Campos, B.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [36] Biweekly administration of docetaxel and gemcitabine for elderly patients with advanced non-small cell lung cancer: A phase II study
    Syrigos, K. N.
    Karapanagiotou, E.
    Charpidou, A.
    Dilana, K.
    Dannos, I.
    Dionellis, G.
    Rigopoulou, A.
    Georgatou, N.
    Roussos, C.
    JOURNAL OF CHEMOTHERAPY, 2007, 19 (04) : 438 - 443
  • [37] Phase II study of erlotinib in chemo-naive women with advanced pulmonary adenocarcinoma
    Jackman, D.
    Lindeman, N. I.
    Lucca, J.
    Morse, L. K.
    Rabin, M. S.
    Marcoux, J. P., III
    Huberman, M.
    Johnson, B. E.
    Janne, P. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [38] Phase II study of docetaxel and cisplatin in advanced non-small-cell lung cancer
    Zalcberg, J
    Millward, M
    Bishop, J
    McKeage, M
    Zimet, A
    Toner, G
    Friedlander, M
    Barter, C
    Rischin, D
    Loret, C
    James, R
    Bougon, N
    Berille, J
    JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (05) : 1948 - 1953
  • [39] Phase II study of carboplatin combined with biweekly docetaxel for advanced non-small cell lung cancer
    Ishimoto, Osamu
    Sugawara, Shunichi
    Inoue, Akira
    Ishida, Takashi
    Munakata, Mitsuru
    Koinumaru, Sadahiro
    Hasegawa, Yukihiro
    Suzuki, Toshiro
    Miki, Hiroshi
    Saijo, Yasuo
    Nukiwa, Toshihiro
    JOURNAL OF THORACIC ONCOLOGY, 2006, 1 (09) : 979 - 983
  • [40] Bevacizumab (B), cisplatin, and vinorelbine in chemotherapy-naive patients (p) with nonsquamous non-small cell lung cancer (NSCLC): A Galician Lung Cancer Group phase II study
    Leon, L.
    Vazquez, S.
    Gracia, J. M.
    Lazaro, M.
    Firvida, J. L.
    Casal, J.
    Amenedo, M.
    Santome, L.
    Gallego, R.
    Anido, U.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
12345